Drug Plan Sustainability in an Era of Specialty Drugs - An Evolving Landscape

April 1, 2015 7:15 AM to 1:00 PMCasino Nova Scotia, Halifax, Nova Scotia
Area of Interest: Benefits Format: In Person

As the Canadian private payer specialty drug reimbursement landscape continues to evolve in Canada, it is valuable for Canadian employers, benefit consultants and advisors to be aware of specialty drug coverage issues and approaches in order to ensure future sustainability of employer drug coverage for specialty drugs. 

Learning objectives include: 

  • Review private payer reimbursement trends in Canada
  • Review the issues and approaches for employers in providing drug coverage for current/future specialty drugs
  • Hepatitis C breakthrough therapies and the implications for plan sponsors

Gain understanding of the offerings and value of manufacturers’ drug patient support programs for employees/patients.

This seminar is sponsored by AbbVie Canada, and speakers include:

  • Tara Anstey; Mercer, Principal 
  • Chris von Hetmann; Cubic Health, Senior Vice President
  • Caroline Lauzon; AbbVie, Patient Support Manager
  • Dr. Lisa Barrett; Dalhousie University, Assistant Professor

This seminar is free to all CPBI members. Breakfast and lunch included. 

Fees and Registration
Membership TypesRegular Price
Regular membership$0.00 CDN
Associate$0.00 CDN
Student$0.00 CDN
Non Member$25.00 CDN
Cancellation Policy

Canadian Employer Drug Plan Sustainability for Specialty Drugs - An Evolving Landscape

Sponsored by AbbVie Canada

April 01, 2015

Casino Nova Scotia, Compass Room

1983 Upper Water Street, Halifax, NS



 7:15      Breakfast

 8:00     Introduction, meeting objectives

  •        Kevin Hollis, Belmont Health & Wealth / Peter Macaulay, Medavie Blue Cross 

 8:10     Private Payer Reimbursement Issues and Challenges for Specialty Drugs

  •       Tara Anstey; Mercer, Principal

 8:45     BioInsights II – Biologics “Playbook” Reference Tool for Advisors

  •        Drug Plan framework for “Biologics Formulary Management” designed by plan advisors
  •        Chris von Heymann; Cubic Health, Senior Vice President 

 9:45     BREAK

10:00   Manufacturers Drug Patient Support Programs – what value do they offer?

  •        Caroline Lauzon; AbbVie, Patient Support Manager

10:30   New Treatment Paradigms in Hepatitis C

  •        Dr. Lisa Barrett; Dalhousie University, Assistant Professor

11:00   How Do We Assure Drug Benefit Plan Sustainability?  A moderated panel discussion

11:45   Meeting Conclusion 

12:00   Optional Lunch